Effect of Aerva lanata on cell-mediated immune responses and cytotoxic T-lymphocyte generation in normal and tumor-bearing mice

Journal of Immunotoxicology

Volumn 9, Issue 1, 2012, Pages 25-33

  Siveen, K S ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Antibody dependent cell mediated cytotoxicity; Antibody dependent complement mediated cytotoxicity; Cytotoxic T lymphocytes; Mixed lymphocyte reaction; NK cell activity

Indexed keywords

AERVA LANATA EXTRACT; GAMMA INTERFERON; HERBACEOUS AGENT; IMMUNOMODULATING AGENT; INTERLEUKIN 2; PLANT EXTRACT; UNCLASSIFIED DRUG;

AERVA LANATA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HERB; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AMARANTHACEAE; ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, EHRLICH TUMOR; COMPLEMENT ACTIVATION; ETHANOL; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-2; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED BALB C; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PLANT EXTRACTS; SOLVENTS; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

AERVA LANATA; MURINAE; MUS;

EID: 84856896583     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2011.609191     Document Type: Article

References (32)

1. Alexeeff G. V., Broadwin R., Liaw J., and Dawson S. V. 2002. Characterization of the LOAEL-to-NOAEL uncertainty factor for mild adverse effects from acute inhalation exposures. Regul. Toxicol. Pharmacol. 36:96-105. (Pubitemid 36160148)
2. Atkinson J. M., Siller C. S., and Gill J. H. 2008. Tumour endoproteases: The cutting edge of cancer drug delivery? Br. J. Pharmacol. 153:1344-1352. (Pubitemid 351481504)
3. Bergmeyer H., and Bernt E. 1980. Colorimetric method for aspartate aniline aminotransferases. In: Practical Clinical Biochemistry, 5th Edition (Varley H., Gowenlock A., and Bell M., Eds.), London: William Heinemann Medical Books Ltd., pp. 741-742.
4. Chopra R. N. (Ed.) 1956. Glossary of Indian medicinal plants. New Delhi: Council of Scientific & Industrial Research, pp. 329.
5. Cooper M. A., Fehniger T. A., and Caligiuri M.A. 2001. The biology of human natural killer cell subsets. Trends Immunol. 22:633-640. (Pubitemid 33043908)
6. Davis L., and Kuttan G. 2002a. Effect of Withania somnifera on cellmediated immune responses in mice. J. Exp. Clin. Cancer Res. 21:585-590. (Pubitemid 36193809)
7. Davis L., and Kuttan G. 2002b. Effect of Withania somnifera on CTL activity. J. Exp. Clin. Cancer Res. 21:115-118. (Pubitemid 34309240)
8. Gorer P. 1950. Studies in antibody response of mice to tumour inoculation. Br. J. Cancer. 4:372-379.
9. Gupta S. K., and Bhattacharya B. 1983. Cytotoxicity assays. In: A Handbook of Practical Immunology (Talwar G. P., Ed.), New Delhi: Vikas Publishing House, pp. 328-333.
10. Jemal A., Tiwari R. C., Murray T., Ghafoor A., Samuels A., Ward E., Feuer E. J., and Thun M. J. 2004. Cancer statistics, 2004. CA Cancer J. Clin. 54:8.
11. Kim Y., Huh N., Koren H., and Amos D. 1980. Natural killing (NK) and antibody-dependent cellular cytotoxicity (ADCC) in specific pathogen-free (SPF) miniature swine and germfree piglets. I. Comparison of NK and ADCC. J. Immunol. 125:755-762. (Pubitemid 10045656)
12. Kindt T. J., Goldsby R. A., Osborne B. A., and Kuby J. (Eds.) 2006. Cellmediated effector responses. In: Kuby Immunology 5th Edition. New York: W.H. Freeman, pp. 319-337.
13. King J. 1965. The phosphatases. In: Practical Clinical Enzymology (Van D., Ed.), London: Nostrand Company Ltd., pp. 91-208.
14. Kobayashi H., Aso H., Ishida N., Maeda H., Pollard R. B., and Suzuki F. 1990. Depletion of macrophages expressing IJ antigen results in efficient generation of alloreactive cytotoxic T-lymphocytes. Cell. Immunol. 128:589-602. (Pubitemid 20211195)
15. Kruisbeek A. M. 2003. Isolation and fractionation of mononuclear cell populations. In: Current Protocols in Immunology (Coligan J. E.., Ed.), New York: John Wiley and Sons, pp. 3.1.1-3.1.5.
16. Kuylenstierna C., Snyder-Cappione J. E., Loo C. P., Long B. R., Gonzalez V. D., Michaelsson J., Moll M., Spotts G., Hecht F. M., Nixon D. F., and Sandberg J. K. 2011. NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infection. Scand. J. Immunol. 73:141-146.
17. Murray R. 1984. Non-protein compounds. In: Clinical Chemistry: Theory, Analysis and Co-relation (Kaplan L., and Pesce A., Eds.), Toronto: Mosby C.V., pp. 1230-1268.
18. Nelson D., and Nelson M. 1987. Evasion of host defences by tumours. Immunol. Cell Biol. 65:287-304.
19. Nevin K. G., and Vijayammal P. L. 2003. Effect of Aerva lanata on solid tumor induced by DLA cells in mice. Fitoterapia 74:578-582. (Pubitemid 36999908)
20. Qu Y., and Li Y. 2010. Progress of study on anti-tumor effects of antibody-dependent cell-mediated cytotoxicity - review. J. Exp. Hematol. Chinese Assoc. Pathophysiol. 18:1370.
21. Sheeja K., and Kuttan G. 2007a. Activation of cytotoxic T-lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide. Immunopharmacol. Immunotoxicol. 29:81-93. (Pubitemid 46676489)
22. Sheeja K., and Kuttan G. 2007b. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice. Integr. Cancer Ther. 6:66-73.
23. Sheeja K., and Kuttan G. 2010. Andrographis paniculata downregulates pro-inflammatory cytokine production and augments cell-mediated immune response in metastatic tumor-bearing mice. Asian Pac. J. Cancer Prev. 11:723-729.
24. Siveen K. S., and Kuttan G. 2011a. Immunomodulatory and anti-tumor activity of Aerva lanata ethanolic extract. Immunopharmacol. Immunotoxicol. 33:423-432.
25. Siveen K. S., and Kuttan G. 2011b. Modulation of humoral immune responses and inhibition of pro-inflammatory cytokines and nitric oxide production by 10-methoxycanthin-6-one. Immunopharmacol. Immunotoxicol. (in press).
26. Thejass P., and Kuttan G. 2006. Augmentation of natural killer cell and antibody-dependent cellular cytotoxicity in BALB/c mice by sulforaphane, a naturally-occurring isothiocyanate from broccoli through enhanced production of cytokines IL-2 and IFN. Immunopharmacol. Immunotoxicol. 28:443-457. (Pubitemid 44451573)
27. Thejass P., and Kuttan G. 2007. Immunomodulatory activity of sulforaphane, a naturally occurring isothiocyanate from broccoli (Brassica oleracea). Phytomedicine 14:538-545. (Pubitemid 47068945)
28. Toro G., and Ackermann P. (Eds.) 1975. Practical Clinical Chemistry. Boston: Little Brown & Co., pp. 154.
29. Vetrichelvan T., and Jegadeesan M. 2002. Anti-diabetic activity of alcoholic extract of Aerva lanata (L.) Juss. Ex Schultes in rats. J. Ethnopharmacol. 80:103-107. (Pubitemid 34462195)
30. Win S., Uenaka A., and Nakayama E. 2002. Immune responses against allogeneic and syngeneic tumors in aged C57BL/6 mice. Microbiol. Immunol. 46:513-519. (Pubitemid 34831217)
31. Zapesochnaya G., Kurkin V., Okhanov V., and Miroshnikov A. 1992. Canthin-6-one and carboline alkaloids from Aerva lanata. Planta Med. 58:192-195.
32. Zapesochnaya G., Pervykh L., and Kurkin V. 1991. A study of the herb Aerva lanata. III. Alkaloids. Chem. Nat. Compd. 27:336-340.